نتائج البحث

Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy.

• Authors : Satake T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/genetics ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/metabolism

• Source: Cancer medicine [Cancer Med] 2024 Dec; Vol. 13 (23), pp. e70474.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?

• Authors : Becker AK; Institute of Pathology, University Hospital RWTH Aachen, 52074, Aachen, Germany.; Puladi B

Subjects: Gene Amplification* ; Liposarcoma*/Liposarcoma*/Liposarcoma*/genetics ; Liposarcoma*/Liposarcoma*/Liposarcoma*/pathology

• Source: World journal of surgical oncology [World J Surg Oncol] 2024 May 17; Vol. 22 (1), pp. 131. Date of Electronic Publication: 2024 May 17.Publisher: BioMed Central Country of Publication: England NLM ID: 101170544 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7819

تفاصيل العنوان

Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.

• Authors : PLOS ONE Editors

• Source: PloS one [PLoS One] 2024 Feb 05; Vol. 19 (2), pp. e0298557. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer.

• Authors : Majumder A; Department of Medicine, University of California, San Francisco, CA 94158, USA.

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/metabolism; Humans

• Source: Cells [Cells] 2023 Oct 25; Vol. 12 (21). Date of Electronic Publication: 2023 Oct 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel.

• Authors : Lyu H; Departments of Interdisciplinary Oncology and Genetics, Stanley S. Scott Cancer Center, School of Medicine, Louisiana State University (LSU) Health Sciences Center, 1700 Tulane Ave, New Orleans, LA, 70112, USA.; Shen F

• Source: Cancer cell international [Cancer Cell Int] 2023 Sep 16; Vol. 23 (1), pp. 204. Date of Electronic Publication: 2023 Sep 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Electronic Cited Medium: Print ISSN: 1475-2867

تفاصيل العنوان

Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer.

• Authors : Dera AA; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 62529, Saudi Arabia.; Zaib S

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/metabolism ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/metabolism; Humans

• Source: Molecules (Basel, Switzerland) [Molecules] 2023 Jun 19; Vol. 28 (12). Date of Electronic Publication: 2023 Jun 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

Expression of Concern: HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.

• Authors : PLOS ONE Editors

• Source: PloS one [PLoS One] 2023 May 24; Vol. 18 (5), pp. e0286446. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Changes in HER3 expression profiles between primary and recurrent gynecological cancers.

• Authors : Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Sudo K

• Source: Cancer cell international [Cancer Cell Int] 2023 Feb 03; Vol. 23 (1), pp. 18. Date of Electronic Publication: 2023 Feb 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101139795 Publication Model: Electronic Cited Medium: Print ISSN: 1475-2867

تفاصيل العنوان

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.

• Authors : Xu T; Department of Immunology, Genetics and Pathology, Uppsala University, 751 85 Uppsala, Sweden.; Schulga A

Subjects: Designed Ankyrin Repeat Proteins* ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/pathology

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 02; Vol. 24 (3). Date of Electronic Publication: 2023 Feb 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

HER3 Alterations in Cancer and Potential Clinical Implications.

• Authors : Kilroy MK; Department of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA.; Park S

• Source: Cancers [Cancers (Basel)] 2022 Dec 14; Vol. 14 (24). Date of Electronic Publication: 2022 Dec 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

تفاصيل العنوان